ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.105
      -0.01%
      Bitcoin
      56,884.87
      -0.81%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/02/20174:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20174:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/01/20174:10PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/01/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/01/201712:31PMGlobeNewswire Inc.Adamas to Present at Two Upcoming Investor ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/22/20178:30AMGlobeNewswire Inc.Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/17/20176:27PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/11/20179:15AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/11/20179:12AMGlobeNewswire Inc.Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty PartnersNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/11/20179:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/09/20174:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/09/20174:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/09/20174:01PMGlobeNewswire Inc.Adamas Reports Recent Achievements and First Quarter 2017 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/05/20175:43PMGlobeNewswire Inc.Adamas Reports Inducement Grant to New Chief Operating OfficerNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/05/20175:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/05/20175:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/02/20174:07PMGlobeNewswire Inc.Adamas to Announce First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/27/20175:51PMGlobeNewswire Inc.Adamas Appoints Richard A. King as Chief Operating Officer to Lead Commercialization of ADS-5102NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/27/20175:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/24/20179:06AMGlobeNewswire Inc.Adamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia an...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/18/20174:04PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/18/20174:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/18/201712:08PMGlobeNewswire Inc.Adamas Announces Oral and Poster Presentations of ADS-5102 Pooled Phase 3 Data at the 69th American Academy of Neurology Annu...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/05/20173:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/28/20171:39PMGlobeNewswire Inc.Adamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual MeetingNASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/28/201710:33AMGlobeNewswire Inc.Adamas to Present at the 16th Annual Needham Healthcare ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20175:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20175:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20175:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS

      Your Recent History

      EU
      MLHPE
      Hopening
      Delayed Upgrade Clock